SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-016502
Filing Date
2023-05-12
Accepted
2023-05-12 08:09:26
Documents
17
Period of Report
2023-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52943
2 ex99-1.htm EX-99.1 113862
3 ex99-2.htm EX-99.2 12724
4 ex99-1_001.jpg GRAPHIC 3633
5 ex99-2_002.jpg GRAPHIC 3633
  Complete submission text file 0001493152-23-016502.txt   438258

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bfri-20230508.xsd EX-101.SCH 4288
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bfri-20230508_def.xml EX-101.DEF 27600
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bfri-20230508_lab.xml EX-101.LAB 38253
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bfri-20230508_pre.xml EX-101.PRE 26217
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6875
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 23913249
SIC: 2834 Pharmaceutical Preparations